itraconazole has been researched along with Candidiasis, Invasive in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Lu, F; Wang, B; Wang, Y; Xu, Y; Zhang, L; Zhang, M | 1 |
Tratrat, C | 1 |
Kooshki, P; Mahmoudabadi, AZ; Rezaei-Matehkolaei, A | 1 |
Alem, N; Karabıçak, N | 1 |
Hsueh, PR; Wang, H; Xu, YC | 1 |
Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Miyazaki, T; Ohno, H; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
Aikawa, N; Fujishima, S; Mikamo, H; Oda, S; Takesue, Y | 1 |
2 review(s) available for itraconazole and Candidiasis, Invasive
Article | Year |
---|---|
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Invasive; Drug Design; Fluconazole; Humans; Itraconazole; Structure-Activity Relationship; Treatment Outcome; Triazoles | 2020 |
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole | 2016 |
1 trial(s) available for itraconazole and Candidiasis, Invasive
Article | Year |
---|---|
Clinical efficacy and safety of intravenous itraconazole in the management of invasive candidiasis in patients of surgery and critical care.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis, Invasive; Critical Care; Female; Humans; Itraconazole; Male; Middle Aged; Prospective Studies; Surgery Department, Hospital; Surgical Procedures, Operative | 2012 |
4 other study(ies) available for itraconazole and Candidiasis, Invasive
Article | Year |
---|---|
Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Candidiasis, Invasive; Critical Illness; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Risk Factors; Voriconazole | 2022 |
The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Infant, Newborn; Infant, Premature; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Voriconazole | 2018 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole | 2016 |
Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Invasive; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Iron; Itraconazole; Lactoferrin; Microbial Sensitivity Tests | 2011 |